Analysts are estimating that Pacira BioSciences will report an earnings per share (EPS) of $0.70.
Anticipation surrounds Pacira BioSciences's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Overview of Past Earnings
Last quarter the company beat EPS by $0.19, which was followed by a 5.68% increase in the share price the next day.
Here's a look at Pacira BioSciences's past performance and the resulting price change:
Quarter
Q2 2024
Q1 2024
Q4 2023
Q3 2023
EPS Estimate
0.70
0.62
0.88
0.79
EPS Actual
0.89
0.62
0.89
0.72
Price Change %
6.0%
12.0%
-3.0%
6.0%
Tracking Pacira BioSciences's Stock Performance
Shares of Pacira BioSciences were trading at $16.45 as of November 04. Over the last 52-week period, shares are down 45.22%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
Analyst Observations about Pacira BioSciences
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Pacira BioSciences.
Analysts have given Pacira BioSciences a total of 7 ratings, with the consensus rating ...
